
|Articles|October 26, 2006
QSV Biologics Appoints New Manager
Author(s)BioPharm International Editors
Malcolm Rollins, PhD, has been appointed manager of projects and process development at QSV Biologics (www.qsvbiologics.com).
Advertisement
Malcolm Rollins, PhD, has been appointed manager of projects and process development at QSV Biologics (
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
2
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
5




